Clinical Trial Update: Trial With Taxotere and Cisplatin in Non-operable Adrenocortical Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Taxotere (docetaxel) with cisplatin in non-operable adrenocortical carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adrenocortical Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Taxotere (docetaxel)

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Adrenocortical Carcinoma | Phase 2 | Status: COMPLETED